HCA Healthcare, Inc. (HCA) is a publicly traded Healthcare sector company. As of October 27, 2026, HCA trades at $479.93 with a market cap of $101.55B and a P/E ratio of 22.61. HCA moved +3.15% today. Year to date, HCA is -1.09%; over the trailing twelve months it is +4.08%. Its 52-week range spans $310.18 to $556.52. Analyst consensus is buy with an average price target of $455.16. Rallies surfaces HCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for HCA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $479.93 |
| Market Cap | $101.55B |
| P/E Ratio | 22.61 |
| EPS | $19.25 |
| Dividend Yield | 0.78% |
| 52-Week High | $556.52 |
| 52-Week Low | $310.18 |
| Volume | 22.37K |
| Avg Volume | 0 |
| Revenue (TTM) | $64.97B |
| Net Income | $6.09B |
| Gross Margin | 0.00% |
21 analysts cover HCA: 0 strong buy, 13 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $455.16.